Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C23H24O6 |
| Molecular Weight | 396.4331 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 5 / 5 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H](O)[C@@H]1O)C2=CC(CC3=CC4=CC=CC=CC4=C3)=CC=C2O
InChI
InChIKey=AGJJCLBOHJQGFA-ZQGJOIPISA-N
InChI=1S/C23H24O6/c24-12-19-20(26)21(27)22(28)23(29-19)17-11-13(6-7-18(17)25)8-14-9-15-4-2-1-3-5-16(15)10-14/h1-7,9-11,19-28H,8,12H2/t19-,20-,21+,22-,23+/m1/s1
ASP-543 (also known as YM-543), a selective inhibitor of the sodium-glucose cotransporter 2. This protein is specifically expressed in the kidney that plays an important role in renal glucose reabsorption, and its inhibition may present a novel therapeutic strategy for treating diabetes. ASP-543 participated in phase II clinical trials in Europe and in the USA for the treatment of Type 2 diabetes mellitus but these studies were discontinued.
Originator
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Pharmacological Characterization of YM543, a Newly Synthesized, Orally Active SGLT2 Selective Inhibitor. | 2013 Aug |
|
| Synthesis and biological evaluation of C-glucosides with azulene rings as selective SGLT2 inhibitors for the treatment of type 2 diabetes mellitus: discovery of YM543. | 2013 Jul 1 |
|
| Evaluation of the Utility of Chimeric Mice with Humanized Livers for the Characterization and Profiling of the Metabolites of a Selective Inhibitor (YM543) of the Sodium-Glucose Cotransporter 2. | 2017 Apr |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
11560307
Created by
admin on Sat Dec 16 11:53:18 GMT 2023 , Edited by admin on Sat Dec 16 11:53:18 GMT 2023
|
PRIMARY | |||
|
00X1DX441H
Created by
admin on Sat Dec 16 11:53:18 GMT 2023 , Edited by admin on Sat Dec 16 11:53:18 GMT 2023
|
PRIMARY | |||
|
655237-16-4
Created by
admin on Sat Dec 16 11:53:18 GMT 2023 , Edited by admin on Sat Dec 16 11:53:18 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
SALT/SOLVATE (PARENT)
